Search global stocks & ETFs...Ctrl K
Learn Mode
EW
Stock Profile
07-22
Recommended Metric
Score Card
Explore Scores Tab
3.63
Good
Valuation Score
Key Score
1.00
Very Bad
Management
5.00
Very Good
Growth
2.00
Bad
Profitability
1.00
Very Bad
Fin. Health
2.00
Bad
Dividends
--
--
Analyst
3.00
Average
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$84.56
Baseline
High
$115.50
▲
36.59%
Avg
$98.18
▲
16.10%
Low
$85.85
▲
1.53%
Analyst Ratings based on 42 Analysts
Strong Buy
1229%
Buy
1945%
Hold
1126%
Sell
000%
Strong Sell
000%
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 16,000 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.Read More
Stock News
View All Updates
News100%Bullish
Should You Continue to Hold EW Stock in Your Portfolio?
3hYahoo
Should You Continue to Hold EW Stock in Your Portfolio?
3hZacks
Calls of the Day: Health Care and Materials
3dCNBC
Possible Bearish Signals With Edwards Lifesciences Insiders Disposing Stock
1wYahoo
Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?
1wYahoo
Is Edwards Lifesciences Stock Underperforming the Nasdaq?
1wYahoo
TD Cowen Maintains Buy on Edwards Lifesciences, Raises Price Target to $104
1wBenzinga
Undervalued Asian Small Caps With Insider Action For June 2026
1wYahoo
10 Health Care Stocks With Whale Alerts In Today's Session
1wBenzinga
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?
2wYahoo
Josh Brown's 'best stocks in the market': Edwards Lifesciences
2wCNBC
Is Edwards Lifesciences (EW) Fairly Priced After Recent Share Price Strength?
2wYahoo
Edwards Lifesciences Has Everything Investors Want Except Value
2wSeekingAlpha
Boston Scientific Bets on WATCHMAN to Drive Structural Heart Growth
2wYahoo
Tulyp Medical Appoints Industry Veteran Steve Motes as CEO to Lead Next Phase of Growth in the US
3wYahoo
VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer
3wYahoo
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?
4wYahoo
Edwards Lifesciences' (NYSE:EW) Conservative Accounting Might Explain Soft Earnings
4wYahoo
Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript
4wSeekingAlpha
Transcript : Edwards Lifesciences Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03
4wFinnhub
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
4wSeekingAlpha
Edwards Lifesciences (EW) is Benefitting from Expanding Its Aortic Valve Franchise
4wYahoo
Edwards names Theodora Mistras as CFO
5wYahoo
Edwards Lifesciences Announces Appointment of CFO
5wYahoo
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
5wYahoo
Edwards Lifesciences Announces Ten-Year Results from Commence Aortic Trial Reinforcing Long-Term Durability of Resilia Tissue
5wFinnhub
Top Research Reports for Philip Morris, Honeywell & Starbucks
5wYahoo
Global's Undervalued Small Caps With Insider Actions For May 2026
6wYahoo
Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings
6wYahoo
How The Edwards Lifesciences (EW) Investment Story Is Shifting As Views On Growth Diverge
6wYahoo
Artisan Global Opportunities Fund Q1 2026 Portfolio Activity
6wSeekingAlpha
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
6wYahoo
Medtronic: Expectations Are Low And That's The Opportunity
6wSeekingAlpha
Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $110
6wBenzinga
Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts
6wSeekingAlpha
EW's Q1 Earnings Beat, Revenues Match, '26 View Up, Stock Climbs
6wYahoo
Edwards Lifesciences raises FY26 guidance following strong Q1
7wYahoo
Edwards Lifesciences Stock Surges On Heart Valve Devices Growth
7wBenzinga
Edwards raises 2026 forecast as TAVR sales surge
7wYahoo
Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Raises Price Target to $93
7wBenzinga
Truist Securities Maintains Hold on Edwards Lifesciences, Raises Price Target to $90
7wBenzinga
Edwards Lifesciences shares are trading higher after Baird and BTIG raised their respective price targets on the stock.
7wBenzinga
Canaccord Genuity Maintains Hold on Edwards Lifesciences, Lowers Price Target to $85
7wBenzinga
Abbott Laboratories: Buying A Healthcare Giant On Sale
7wSeekingAlpha
Edwards Lifesciences Corp (EW) Q1 2026 Earnings Call Highlights: Strong Sales Growth and Raised ...
7wYahoo
BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $100
7wBenzinga
Baird Maintains Neutral on Edwards Lifesciences, Raises Price Target to $87
7wBenzinga
Edwards Lifesciences Q1 Earnings Call Highlights
7wYahoo
The 'Standout' From Edwards Lifesciences' Broad-Based Sales Beat
7wYahoo
Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics
7wYahoo